metuximab
mAbexperimentalADC
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
2
Earliest trial started Dec 1, 2008 (NCT00819650)
Timeline
2000s
- Jan 1, 2008
Earliest Phase 2 Sponsor(trial)
Indications
Approved for
Mechanism of action
- BasiginBINDING AGENT
BSG binding agent
Chemistry & pharmacology
- Payload
- 131-iodine
Oral
No
Parenteral
No
Topical
No
Also known as
- licartin
- licartin
- metuximab
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01758679 | Phase 4 | Jan 1, 2012 | Nanjing Medical University |
| NCT00819650 | Phase 2 | Dec 1, 2008 | Eastern Hepatobiliary Surgery Hospital |
| NCT00829465 | Phase 4 | Dec 1, 2008 | Eastern Hepatobiliary Surgery Hospital, People's Liberation Army of China |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Eastern Hepatobiliary Surgery Hospital | Academic/Hospital | 2 | 2 | 2 | 2008 |
| Nanjing Medical University | Academic/Hospital | 1 | 1 | 1 | 2012 |
| People's Liberation Army of China | Government | 1 | 0 | 1 | 2008 |
3 organizations
Page 1 / 1